Home > Medical Research Archives > Issue 149 > Development of a COVID-19 Vaccine Hesitancy Single Session Group Intervention for US Veterans
Published in the Medical Research Archives
Dec 2022 Issue
Development of a COVID-19 Vaccine Hesitancy Single Session Group Intervention for US Veterans
Published on Dec 21, 2022
DOI
Abstract
Background: COVID-19 vaccine hesitancy remains problematic and is particularly prevalent in minority and underserved communities.
Aim and Scope: The development and initial efficacy of a single-session Vaccine Hesitancy-focused Telehealth Group at a Veterans hospital in the Bronx, NY are described. This single-session telehealth group integrated motivational interviewing, psychoeducation, and a “vaccine positive” peer with the goal of addressing COVID-19 vaccine hesitancy and improving vaccination rates.
Methods: This project was approved by the quality assurance and improvement team at the James J. Peters VA Medical Center in the Bronx, NY. From the vaccine-hesitant Veteran referrals received from providers, eight vaccine hesitancy groups, averaging 3.5 participants per session, were conducted. Thirty Veterans total participated in the telehealth group.
Results: Two-thirds of the participants have received the COVID-19 vaccine, with the vast majority of participants receiving the vaccine after the group. About half of the participants (n=14) were more willing to get the vaccine following the intervention and none experienced an increase in hesitancy.
Conclusions: Preliminary results suggest this may be one intervention to increase vaccine acceptability and COVID-19 vaccination rates. Program strengths, limitations, and suggestions are discussed.
Author info
Author Area
Have an article to submit?
Submission Guidelines
Submit a manuscript
Become a member